“We are very excited to join forces with PerformRx and offer our clinical services to their clients,” said Chris Chan, PharmD, Co-Founder and Chief Clinical Officer of Gojji."
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
